266 related articles for article (PubMed ID: 21191613)
1. An unusual and potentially misleading phenotypic change in a primary gastrointestinal stromal tumour (GIST) under imatinib mesylate therapy.
Vassos N; Agaimy A; Schlabrakowski A; Hohenberger W; Schneider-Stock R; Croner RS
Virchows Arch; 2011 Mar; 458(3):363-9. PubMed ID: 21191613
[TBL] [Abstract][Full Text] [Related]
2. Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy.
Antonescu CR; Romeo S; Zhang L; Nafa K; Hornick JL; Nielsen GP; Mino-Kenudson M; Huang HY; Mosquera JM; Dei Tos PA; Fletcher CD
Am J Surg Pathol; 2013 Mar; 37(3):385-92. PubMed ID: 23348204
[TBL] [Abstract][Full Text] [Related]
3. Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall.
Pauwels P; Debiec-Rychter M; Stul M; De Wever I; Van Oosterom AT; Sciot R
Histopathology; 2005 Jul; 47(1):41-7. PubMed ID: 15982322
[TBL] [Abstract][Full Text] [Related]
4. Familial gastrointestinal stromal tumor syndrome: report of 2 cases with KIT exon 11 mutation.
Jones DH; Caracciolo JT; Hodul PJ; Strosberg JR; Coppola D; Bui MM
Cancer Control; 2015 Jan; 22(1):102-8. PubMed ID: 25504284
[TBL] [Abstract][Full Text] [Related]
5. [A case of gastric GIST treated preoperatively by imatinib mesylate].
Hiramatsu Y; Konno H; Kamiya K; Baba M; Ohta M; Kondo K; Yamamoto M; Kikuchi H; Tanaka T; Sugimura H; Nakamura S
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1219-23. PubMed ID: 15332547
[TBL] [Abstract][Full Text] [Related]
6. Imatinib treatment for gastrointestinal stromal tumour (GIST).
Lopes LF; Bacchi CE
J Cell Mol Med; 2010 Jan; 14(1-2):42-50. PubMed ID: 19968734
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate.
Yeh CN; Chen TW; Wu TJ; Hsueh S; Jan YY
World J Gastroenterol; 2006 Jun; 12(23):3760-5. PubMed ID: 16773696
[TBL] [Abstract][Full Text] [Related]
8. Primary gastrointestinal stromal tumor of the liver with lung metastases successfully treated with STI-571 (imatinib mesylate).
De Chiara A; De Rosa V; Lastoria S; Franco R; Botti G; Iaffaioli VR; Apice G
Front Biosci; 2006 Jan; 11():498-501. PubMed ID: 16146747
[TBL] [Abstract][Full Text] [Related]
9. Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy.
Annaberdyev S; Gibbons J; Hardacre JM
World J Surg Oncol; 2009 Mar; 7():30. PubMed ID: 19291285
[TBL] [Abstract][Full Text] [Related]
10. [Gastrointestinal stromal tumor of small intestine associated with lymph node metastasis: a report of 2 cases with review of literatures].
Kong M; Wang YL; Xu LJ; Teng XD
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):617-20. PubMed ID: 20079191
[TBL] [Abstract][Full Text] [Related]
11. [Chinese consensus in diagnosis and treatment of gastrointestinal stromal tumor].
Chinese Diagnosis and Treatment Experts Group for Gastrointestinal Stromal Tumors
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):697-702. PubMed ID: 20078976
[No Abstract] [Full Text] [Related]
12. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases.
Herawi M; Montgomery EA; Epstein JI
Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs).
Rutkowski P; Nowecki ZI; Debiec-Rychter M; Grzesiakowska U; Michej W; Woźniak A; Siedlecki JA; Limon J; vel Dobosz AJ; Kakol M; Osuch C; Ruka W
J Cancer Res Clin Oncol; 2007 Sep; 133(9):589-97. PubMed ID: 17458563
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumor of unusual phenotype after imatinib treatment: A case report and diagnostic utility of ETV1 mRNA in situ hybridization.
Jung M; Park SH; Jeon YK; Won JK; Yang HK; Kim WH
Medicine (Baltimore); 2017 Dec; 96(49):e9031. PubMed ID: 29245294
[TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
16. A hemodialysis patient with primary extra-gastrointestinal stromal tumor: favorable outcome with imatinib mesylate.
Wada Y; Ogata H; Misawa S; Shimada A; Kinugasa E
Intern Med; 2012; 51(12):1561-5. PubMed ID: 22728491
[TBL] [Abstract][Full Text] [Related]
17. Emergence of imatinib resistance associated with downregulation of c-kit expression in recurrent gastrointestinal stromal tumor (GIST): optimal timing of resection.
Dudeja V; Armstrong LH; Gupta P; Ansel H; Askari S; Al-Refaie WB
J Gastrointest Surg; 2010 Mar; 14(3):557-61. PubMed ID: 20033343
[TBL] [Abstract][Full Text] [Related]
18. Advanced gastrointestinal stromal tumor patients with complete response after treatment with imatinib mesylate.
Chiang KC; Chen TW; Yeh CN; Liu FY; Lee HL; Jan YY
World J Gastroenterol; 2006 Apr; 12(13):2060-4. PubMed ID: 16610057
[TBL] [Abstract][Full Text] [Related]
19. Extra-gastrointestinal stromal tumor of the pelvic cavity: case report.
Hirano H; Yoshida T; Yoshimura H; Fukuoka M; Ohmura N; Nishizawa Y; Tachibana S; Hirota S; Zozumi M; Nishigami T
Med Mol Morphol; 2012 Jun; 45(3):173-7. PubMed ID: 23001300
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary treatment of gastrointestinal stromal tumors.
Kingham TP; DeMatteo RP
Surg Clin North Am; 2009 Feb; 89(1):217-33, x. PubMed ID: 19186237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
